Nazareth
Nazareth
Nazareth, Israel12 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN) | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, autoimmune disease, chronic renal failure syndrome, glomerulonephritis, immune system disorder, kidney disorder, kidney failure, nephritis, proteinuria, urinary system disorder | Active, not recruiting | Phase 3 | 2026-10-02 | NCT06291376 | |
| TENS Use for Post-cesarean Pain Management | Post Cesarean Pain Management | Not yet recruiting | Not applicable | 2026-09-28 | NCT07777939 | |
| TENS for Postpartum Uterine Pain During Breastfeeding | Breast Feeding | Recruiting | Not applicable | 2026-09-28 | NCT07703917 | |
| A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder | Active, not recruiting | Phase 3 | 2026-09-25 | NCT05757869 | |
| Maternal Outcomes Following Manual Lysis of the Placenta. | Female Urogenital Diseases and Pregnancy Complications, Hemorrhage, Obstetric Labor Complications, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postpartum Hemorrhage, Urogenital Diseases, Uterine Hemorrhage, pregnancy disorder, puerperal disorder | Recruiting | Not applicable | 2026-08-17 | NCT03626844 | |
| A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis | Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease | Active, not recruiting | Phase 3 | 2026-06-01 | NCT03900429 | |
| Ultrasound for Assessment of Intra-Abdominal Blood Loss After Gynecological Surgery | Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Hemorrhage, disease | Recruiting | Not stated | 2026-04-13 | NCT06953141 | |
| Programmed Intermittent Epidural Bolus Compared With Continuous Infusion in Multiparous Women | Breakthrough Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Recruiting | Not applicable | 2026-04-13 | NCT06580327 | |
| PIEB Compared With CEI on Breakthrough Pain in Nulliparous Women | Breakthrough Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Recruiting | Not applicable | 2026-04-13 | NCT06494280 | |
| Castor Oil Ingestion and Balloon Catheter for Labor Induction in Multiparous | Induction of Labor | Recruiting | Not applicable | 2026-04-13 | NCT06335017 | |
| Castor Oil Ingestion and Balloon Catheter for Labor Induction in Nulliparous | Induction of Labor Affected Fetus / Newborn | Recruiting | Not applicable | 2026-04-13 | NCT06325007 | |
| Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756) | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 3 | 2025-07-11 | NCT03725059 |